Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines
Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines
批准号:
10587705
负责人:
Gaurav Sahay
金额:
$57.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-10 至 2027-12-31
关键词:
3-DimensionalAddressBar CodesBasic ScienceBiodistributionBiologicalBiological AssayBiological ProcessBiophysicsBreast Cancer therapyCancer ModelCellsCharacteristicsChemical StructureChemicalsClinicalCombined Modality TherapyDNADataDevelopmentDiffusionDiseaseDoseEndosomesEngineeringFormulationFutureGene DeliveryGoalsHealthcareHeelHistopathologyImmunohistochemistryImmunologicsIn VitroKnowledgeLabelLibrariesLuciferasesMalignant NeoplasmsMeasurementMessenger RNAMethodologyMigration AssayModificationMolecularMolecular TargetNanotechnologyOncologistOncologyOrganOutcomes ResearchPeriodicityPopulationProcessPropertyProteinsProtocols documentationRNARNA InterferenceRNA deliveryRadiation therapyRadiosensitizationRare DiseasesRoleRouteSchemeSeriesSolid NeoplasmStructureStructure-Activity RelationshipSystemTechnologyTestingTherapeuticTissuesTransfectionTreatment EfficacyTreatment ProtocolsTumor VolumeVaccinesViscositybiological systemsbioluminescence imagingcalreticulincancer cellcell killingchemotherapyclinical translationclinically relevantcomplex biological systemsdesigndosageeffectiveness evaluationexpectationexperiencegene therapyhydrophilicityimmunoregulationimprovedin vivoindividualized medicineinsightlipid nanoparticlemouse modelmultidisciplinarymultimodalitymutantnanoengineeringnanomaterialsnanomedicinenanoparticlenovelnovel strategiespreclinical studyradiation effecttherapeutic RNAtooltraffickingtumortumor microenvironmentuptakevaccine developmentvaccine distribution
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
RNA therapeutics and their corresponding nanomedicines are poised to rapidly change the landscape of
healthcare. To address needs in various diseases, RNA-based technologies must function in vivo with
biological interactions at various levels from whole body (systemic biodistribution and immunological) to
tissues and organs, to intracellular trafficking and endosomal release. Unfortunately in oncology, efficient
systemic delivery of lipid nanoparticles (LNPs) to solid tumors has been plagued by poor tissue
accumulation largely due to a gap in the knowledge of fundamental interactions between these materials
and biological systems. Here we propose to investigate the structure-activity-relationship (SAR) of
nanoparticle carriers through use of a chemically and topologically diverse library of lipopolymers fine-
tuning the biointerface of RNA-LNP. Utilizing a combined barcoding and serial in-depth mechanistic
assays, we will test our central hypothesis that a defined series of first-principles relationships govern the
biophysical interactions of LNPs in vivo. Using cancer models, we will correlate the spatial and temporal
accumulation of mRNA at target tissues and cells with biophysicochemical properties of the LNP
biointerface. The goal of this project is to establish a framework of physiochemical properties to guide the
development of RNA-LNP based cancer nanomedicines. We will achieve this goal by the pursuing the
following aims: Aim 1 - Structural and topological fine-tuning of LNPs biointerface. Aim 2 - Elucidate the
biological interactions of LNPs with respect to whole-body, tissue-level, and intracellular distributions. Aim
3 - Investigate the biological interaction and efficacy of LNPs in the context of multimodal breast cancer
therapy. The immediate outcomes of this research will be applied toward advancing the use of
nanotechnology in oncology. Our project will yield a critical and detailed understanding of the role the LNP
biointerface and its effects on the fate of LNPs in complex biological systems as well as their efficacy. This
invaluable knowledge would greatly aid in future developments in nanomedicine as a whole.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing gene editing platforms for retinal degeneration.
-
批准号:10522389
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2022
-
负责人:Gaurav Sahay
-
依托单位:
Developing gene editing platforms for retinal degeneration.
-
批准号:10707472
-
项目类别:
-
资助金额:$62.71万
-
财政年份:2022
-
负责人:Gaurav Sahay
-
依托单位:
Overcoming gene delivery barriers to the back of the eye
-
批准号:10250546
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2020
-
负责人:Gaurav Sahay
-
依托单位:
Overcoming gene delivery barriers to the back of the eye
-
批准号:10058049
-
项目类别:
-
资助金额:$23.81万
-
财政年份:2020
-
负责人:Gaurav Sahay
-
依托单位:
Nanoparticles based mRNA delivery for treatment of cystic fibrosis
-
批准号:10563195
-
项目类别:
-
资助金额:$65.86万
-
财政年份:2019
-
负责人:Gaurav Sahay
-
依托单位:
Nanoparticles based mRNA delivery for treatment of cystic fibrosis
-
批准号:9898461
-
项目类别:
-
资助金额:$66.67万
-
财政年份:2019
-
负责人:Gaurav Sahay
-
依托单位:
Nanoparticles based mRNA delivery for treatment of cystic fibrosis
-
批准号:10360481
-
项目类别:
-
资助金额:$65.86万
-
财政年份:2019
-
负责人:Gaurav Sahay
-
依托单位:
Mechanisms of Intracellular trafficking and endosomal escape of nanoparticles for mRNA delivery
-
批准号:9232538
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2017
-
负责人:Gaurav Sahay
-
依托单位:
海外基金